Traditional corticosteroids for induction of remission in Crohn's disease-Reference-Cited by-同舟云学术

Traditional corticosteroids for induction of remission in Crohn's disease

Published:2008-04-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Benchimol Eric I¹,Seow Cynthia H²,Steinhart A Hillary³,Griffiths Anne Marie⁴

Affiliation:

1. The Children's Hospital of Eastern Ontario; Division of Gastroenterology Hepatology & Nutrition; 401 Smyth Road Ontario Ottawa Canada K1H 8L1

2. University of Calgary; Departments of Medicine & Community Health Sciences; TRW Building Rm 6D18 3280 Hospital Drive NW Calgary Alberta Canada T2N 4Z6

3. University of Toronto; Department of Medicine; Room 445, 600 University Avenue Mount Sinai Hospital Toronto Ontario Canada M5G 1X5

4. The Hospital for Sick Children; Division of Gastroenterology, Hepatology & Nutrition; 555 University Ave. Toronto Ontario Canada M5G 1X8

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD006792.pub2/fullpdf

Reference58 articles.

1. Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group;Gross;Z Gastroenterol,1995

2. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment;Malchow;Gastroenterology,1984

3. Oral 5-ASA versus prednisone in short term treatment of Crohn's disease: A multicentre controlled trial;Martin;Can J Gastroenterol,1990

4. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial;Prantera;Gastroenterology,1999

5. Oral 5-aminosalicylic acid versus 6-methylprednisolone in active Crohn's disease;Scholmerich;Can J Gastroenterol,1990

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting;Digestive and Liver Disease;2024-01

2. Crohn's disease and clinical management today: How it does?;World Journal of Methodology;2023-12-20

3. Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme;Journal of Crohn's and Colitis;2023-11-06

4. Therapeutic potential and mechanism of functional oligosaccharides in inflammatory bowel disease: a review;Food Science and Human Wellness;2023-11

5. Clinical guidelines. Crohn’s disease (К50), adults;Koloproktologia;2023-09-21